Abstract
Over the past decade our understanding of dry eye has greatly increased, but the number affected by the condition has also risen. It is estimated 1 of 5 Americans suffers from dry eye1 and about 7-10 million currently require artificial tear preparations to treat its symptoms. 2 The rise in dry eye may be due to several factors, including adverse environments, increased visual tasking (e.g., personal computers and television) and the more frequent use of systemic antihistamines. The increased prevalence has led to the need for an even better understanding of the disease and its therapeutic approaches. Consequently, tremendous improvements have occurred in the accuracy and preciseness of the diagnostic tools used to evaluate the condition.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Eagle Vision and Yankelovich Partners Survey. Cited by: Segrè L. Advanced Technology: Reshaping the Future of Vision Care. Available at:http://www.optistock.com.
Kaswan R. Cyclosporin drops: a potential breakthrough for dry eyes. In: Research to Prevent Blindness Science Writers Seminar. New York: Research to Prevent Blindness; 1989:18–20. Cited by: Oden NL, Lilienfeld DE, Lemp MA, Nelson JD, Ederer F. Sensitivity and specificity or a screening questionnaire for dry eye. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. ed Sullivan DA, Dart DA, Meneray MA. New York: Plenum Press; 1998:807–820.
Cho P, Brown B. Review of the tear break up time and a closer look at the tear break up time of Hong Kong Chinese. Optom Vis Sci. 1993;70(1):30–8.
Lemp MA, Dohlman CH, Holly FJ. Corneal desiccation despite normal tear volume. Annals of Ophthalmology. 1970; 284: 258–261.
Lemp MA. Report of National Eye Institute/Industry Workshop on clinical trials in dry eyes. CIAO J. 1995;21:221–232.
Marquardt R, Stodtmeiser R, Christ T. Modification of tear film breakup time test for increased reliability. In: Holly FJ, ed. The Preocular Tear Film in Health, Disease and Contact Lens Wear. Lubbock, Texas: Dry Eye Institute, 1986:57–63.
Korb DR, Finnemore VM, Herman JP, et al. A new method for the fluorescein breakup time test. ARVO Abstracts. Invest Ophthalmol. 1998;40:B748.
Korb DR, Finnemore VM, Herman JP, et al. The DETTM test—a new method for dry eye/tear film evaluation. ARVO Abstracts. Invest Ophthalmol. 1999;41:B809.
Abdul-Fattah AM, Bhargava HN, Korb DR, et al. Quantitative in vitro comparison of fluorescein delivery to the eye via impregnated strip and volumetric techniques. ARVO Abstracts. Invest Ophthalmol. 1998;40:B747.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Abelson, M.B., Ousler, G.W., Nally, L.A., Welch, D., Krenzer, K. (2002). Alternative Reference Values for Tear Film Break up Time in Normal and Dry Eye Populations. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_157
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0717-8_157
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5208-2
Online ISBN: 978-1-4615-0717-8
eBook Packages: Springer Book Archive